Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
The price of Kiniksa Pharmaceuticals International Plc (NASDAQ: KNSA) closed at $27.74 in the last session, up 2.86% from day before closing price of $26.97. In other words, the price has increased by $2.86 from its previous closing price. On the day, 1.1 million shares were traded. KNSA stock price reached its highest trading level at $28.12 during the session, while it also had its lowest trading level at $26.63.
Ratios:
We take a closer look at KNSA’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 7.54 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 46.28. For the most recent quarter (mrq), Quick Ratio is recorded 3.43 and its Current Ratio is at 3.66. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Citigroup on March 13, 2025, initiated with a Buy rating and assigned the stock a target price of $40.
On September 13, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $40.
On May 03, 2024, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $34.Wells Fargo initiated its Overweight rating on May 03, 2024, with a $34 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Apr 29 ’25 when Moat Ross sold 64,035 shares for $25.21 per share. The transaction valued at 1,614,322 led to the insider holds 9,415 shares of the business.
Moat Ross sold 23,234 shares of KNSA for $651,017 on May 01 ’25. The CHIEF COMMERCIAL OFFICER now owns 9,415 shares after completing the transaction at $28.02 per share. On Apr 29 ’25, another insider, Ragosa Mark, who serves as the CHIEF FINANCIAL OFFICER of the company, sold 42,000 shares for $25.61 each. As a result, the insider received 1,075,620 and left with 27,009 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, KNSA now has a Market Capitalization of 2024215552 and an Enterprise Value of 1765789568. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.21 while its Price-to-Book (P/B) ratio in mrq is 4.41. Its current Enterprise Value per Revenue stands at 3.67 whereas that against EBITDA is -124.107.
Stock Price History:
The Beta on a monthly basis for KNSA is 0.07, which has changed by 0.38147414 over the last 52 weeks, in comparison to a change of 0.092895746 over the same period for the S&P500. Over the past 52 weeks, KNSA has reached a high of $28.15, while it has fallen to a 52-week low of $17.38. The 50-Day Moving Average of the stock is 28.41%, while the 200-Day Moving Average is calculated to be 22.60%.
Shares Statistics:
According to the various share statistics, KNSA traded on average about 663.99K shares per day over the past 3-months and 839120 shares per day over the past 10 days. A total of 42.16M shares are outstanding, with a floating share count of 40.47M. Insiders hold about 44.53% of the company’s shares, while institutions hold 56.42% stake in the company. Shares short for KNSA as of 1744675200 were 3316011 with a Short Ratio of 4.99, compared to 1741910400 on 3072555. Therefore, it implies a Short% of Shares Outstanding of 3316011 and a Short% of Float of 10.13.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
